CVS Health Co. (NYSE:CVS) Shares Sold by Sei Investments Co.

Sei Investments Co. reduced its stake in CVS Health Co. (NYSE:CVS) by 24.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 715,854 shares of the pharmacy operator’s stock after selling 230,350 shares during the period. Sei Investments Co.’s holdings in CVS Health were worth $32,133,000 as of its most recent SEC filing.

Other institutional investors also recently made changes to their positions in the company. Eagle Asset Management Inc. acquired a new position in shares of CVS Health during the third quarter valued at $2,795,000. Nwam LLC acquired a new stake in shares of CVS Health in the third quarter valued at approximately $230,000. Larson Financial Group LLC increased its stake in shares of CVS Health by 258.9% in the third quarter. Larson Financial Group LLC now owns 3,542 shares of the pharmacy operator’s stock valued at $223,000 after purchasing an additional 2,555 shares during the period. Westfield Capital Management Co. LP acquired a new position in shares of CVS Health during the third quarter worth approximately $663,000. Finally, Daiwa Securities Group Inc. boosted its position in shares of CVS Health by 12.1% during the third quarter. Daiwa Securities Group Inc. now owns 153,359 shares of the pharmacy operator’s stock worth $9,643,000 after buying an additional 16,549 shares during the period. 80.66% of the stock is owned by institutional investors.

Insider Buying and Selling at CVS Health

In related news, Director Michael F. Mahoney acquired 30,000 shares of the company’s stock in a transaction on Tuesday, February 18th. The shares were purchased at an average price of $66.70 per share, for a total transaction of $2,001,000.00. Following the purchase, the director now owns 39,356 shares in the company, valued at $2,625,045.20. This represents a 320.65 % increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, SVP James David Clark sold 7,513 shares of CVS Health stock in a transaction on Wednesday, March 5th. The shares were sold at an average price of $66.35, for a total transaction of $498,487.55. Following the sale, the senior vice president now directly owns 8,394 shares of the company’s stock, valued at $556,941.90. This trade represents a 47.23 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 0.24% of the company’s stock.

CVS Health Stock Performance

Shares of CVS opened at $66.54 on Wednesday. The company has a 50-day moving average of $61.22 and a two-hundred day moving average of $57.46. The stock has a market cap of $83.89 billion, a price-to-earnings ratio of 18.18, a PEG ratio of 0.98 and a beta of 0.54. The company has a debt-to-equity ratio of 0.80, a current ratio of 0.81 and a quick ratio of 0.60. CVS Health Co. has a one year low of $43.56 and a one year high of $80.75.

CVS Health (NYSE:CVS) last posted its quarterly earnings data on Wednesday, February 12th. The pharmacy operator reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.30. CVS Health had a net margin of 1.24% and a return on equity of 9.11%. On average, equities research analysts expect that CVS Health Co. will post 5.89 earnings per share for the current year.

CVS Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, May 1st. Shareholders of record on Tuesday, April 22nd will be given a dividend of $0.665 per share. The ex-dividend date is Tuesday, April 22nd. This represents a $2.66 dividend on an annualized basis and a yield of 4.00%. CVS Health’s payout ratio is presently 72.68%.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on CVS shares. Evercore ISI lifted their target price on CVS Health from $60.00 to $65.00 and gave the company an “outperform” rating in a research note on Monday, January 27th. JPMorgan Chase & Co. upped their price objective on shares of CVS Health from $80.00 to $81.00 and gave the stock an “overweight” rating in a report on Tuesday, February 18th. Argus set a $77.00 target price on shares of CVS Health in a research note on Tuesday, February 18th. StockNews.com raised shares of CVS Health from a “sell” rating to a “hold” rating in a research note on Thursday, February 13th. Finally, Barclays boosted their target price on CVS Health from $71.00 to $73.00 and gave the stock an “overweight” rating in a report on Thursday, February 13th. Four research analysts have rated the stock with a hold rating, seventeen have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat.com, CVS Health presently has a consensus rating of “Moderate Buy” and an average price target of $70.39.

CVS Health Profile

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.